ZIMMER BIOMET HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 119.3 USD | -1.62% |
|
-6.42% | -1.95% |
| Apr. 15 | Truist Securities Adjusts Zimmer Biomet Price Target to $137 From $135, Hold Rating Kept | MT |
| Apr. 04 | Zimmer Biomet Partners with Three Pickleball Organizations in US | MT |
Presenter SpeechAndrew Ranieri (Analysts)All right. Thanks, everyone, for joining us today for...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows:
- reconstruction implants (57.5%): knees replacement (58.8% of net sales), hips replacement (41.2%);
- surgical products and traumatology equipment (22.1%);
- dental, spinal and craniomaxillofacial implants (12.8%);
- other (7.6%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation.
At the end of 2021, the group had approximately 30 production sites worldwide.
Net sales are distributed geographically as follows: Americas (61.3%), Europe/Middle East/Africa (21.3%) and Asia/Pacific (17.4%).
Calendar
2024-05-02
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
119.3
USD
Average target price
137.1
USD
Spread / Average Target
+14.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.95% | 24.52B | |
| -4.36% | 183B | |
| -3.87% | 105B | |
| -4.38% | 67.36B | |
| +8.23% | 51.77B | |
| +15.54% | 47.29B | |
| -1.73% | 40.2B | |
| +7.16% | 27.62B | |
| -17.79% | 21.75B | |
| -1.68% | 25.51B |
- Stock Market
- Equities
- ZBH Stock
- News Zimmer Biomet Holdings, Inc.
- Transcript : Zimmer Biomet Holdings, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-12-2022 10
